205 related articles for article (PubMed ID: 35332984)
1. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.
Hare PJ; Englander HE; Mok WWK
J Appl Microbiol; 2022 Jun; 132(6):4020-4032. PubMed ID: 35332984
[TBL] [Abstract][Full Text] [Related]
2. The AcrAB-TolC Efflux Pump Impacts Persistence and Resistance Development in Stationary-Phase Escherichia coli following Delafloxacin Treatment.
Byrd BA; Zenick B; Rocha-Granados MC; Englander HE; Hare PJ; LaGree TJ; DeMarco AM; Mok WWK
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0028121. PubMed ID: 34097492
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress in persister tolerance.
Wu Y; Vulić M; Keren I; Lewis K
Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
[TBL] [Abstract][Full Text] [Related]
4. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
Völzing KG; Brynildsen MP
mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
[TBL] [Abstract][Full Text] [Related]
5. Ploidy is an important determinant of fluoroquinolone persister survival.
Murawski AM; Brynildsen MP
Curr Biol; 2021 May; 31(10):2039-2050.e7. PubMed ID: 33711253
[TBL] [Abstract][Full Text] [Related]
6.
Mohiuddin SG; Massahi A; Orman MA
mBio; 2022 Feb; 13(1):e0218721. PubMed ID: 35038905
[TBL] [Abstract][Full Text] [Related]
7. Toxin Induction or Inhibition of Transcription or Translation Posttreatment Increases Persistence to Fluoroquinolones.
Lemma AS; Brynildsen MP
mBio; 2021 Aug; 12(4):e0198321. PubMed ID: 34399616
[TBL] [Abstract][Full Text] [Related]
8. Differential impacts of DNA repair machinery on fluoroquinolone persisters with different chromosome abundances.
Tang J; Herzfeld AM; Leon G; Brynildsen MP
mBio; 2024 May; 15(5):e0037424. PubMed ID: 38564687
[TBL] [Abstract][Full Text] [Related]
9. Zinc Acetate Potentiates the Action of Tosufloxacin against Escherichia coli Biofilm Persisters.
Usui M; Yokoo H; Tamura Y; Nakajima C; Suzuki Y; Ghigo JM; Beloin C
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936108
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
Barrett TC; Mok WWK; Murawski AM; Brynildsen MP
Nat Commun; 2019 Mar; 10(1):1177. PubMed ID: 30862812
[TBL] [Abstract][Full Text] [Related]
11. Persister Escherichia coli Cells Have a Lower Intracellular pH than Susceptible Cells but Maintain Their pH in Response to Antibiotic Treatment.
Goode O; Smith A; Zarkan A; Cama J; Invergo BM; Belgami D; Caño-Muñiz S; Metz J; O'Neill P; Jeffries A; Norville IH; David J; Summers D; Pagliara S
mBio; 2021 Aug; 12(4):e0090921. PubMed ID: 34281389
[TBL] [Abstract][Full Text] [Related]
12. An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic.
Adediran J; Leatham-Jensen MP; Mokszycki ME; Frimodt-Møller J; Krogfelt KA; Kazmierczak K; Kenney LJ; Conway T; Cohen PS
Infect Immun; 2014 Feb; 82(2):670-82. PubMed ID: 24478082
[TBL] [Abstract][Full Text] [Related]
13. SOS response induces persistence to fluoroquinolones in Escherichia coli.
Dörr T; Lewis K; Vulić M
PLoS Genet; 2009 Dec; 5(12):e1000760. PubMed ID: 20011100
[TBL] [Abstract][Full Text] [Related]
14. Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany.
Kleta S; Steinrück H; Breves G; Duncker S; Laturnus C; Wieler LH; Schierack P
J Appl Microbiol; 2006 Dec; 101(6):1357-66. PubMed ID: 17105567
[TBL] [Abstract][Full Text] [Related]
15. Host Cell Oxidative Stress Promotes Intracellular Fluoroquinolone Persisters of Streptococcus pneumoniae.
Hernandez-Morfa M; Reinoso-Vizcaíno NM; Olivero NB; Zappia VE; Cortes PR; Jaime A; Echenique J
Microbiol Spectr; 2022 Dec; 10(6):e0436422. PubMed ID: 36445159
[TBL] [Abstract][Full Text] [Related]
16. Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data.
Sun J; Gunzer F; Westendorf AM; Buer J; Scharfe M; Jarek M; Gössling F; Blöcker H; Zeng AP
J Biotechnol; 2005 May; 117(2):147-61. PubMed ID: 15823404
[TBL] [Abstract][Full Text] [Related]
17. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition.
Aedo SJ; Orman MA; Brynildsen MP
BMC Microbiol; 2019 Jun; 19(1):140. PubMed ID: 31234796
[TBL] [Abstract][Full Text] [Related]
18. Resuscitation dynamics reveal persister partitioning after antibiotic treatment.
Fang X; Allison KR
Mol Syst Biol; 2023 Apr; 19(4):e11320. PubMed ID: 36866643
[TBL] [Abstract][Full Text] [Related]
19. Rapid Freezing Enables Aminoglycosides To Eradicate Bacterial Persisters via Enhancing Mechanosensitive Channel MscL-Mediated Antibiotic Uptake.
Zhao Y; Lv B; Sun F; Liu J; Wang Y; Gao Y; Qi F; Chang Z; Fu X
mBio; 2020 Feb; 11(1):. PubMed ID: 32047133
[TBL] [Abstract][Full Text] [Related]
20. Timing of DNA damage responses impacts persistence to fluoroquinolones.
Mok WWK; Brynildsen MP
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6301-E6309. PubMed ID: 29915065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
